Glycated Serum Proteins D000093422

Related MeSH Hierarchy (5)

Chemicals and Drugs [D] » Carbohydrates [D09] » Glycoconjugates » Glycation End Products, Advanced » Glycated Proteins » Glycated Serum Proteins

Chemicals and Drugs [D] » Carbohydrates [D09] » Glycoconjugates » Glycoproteins » Glycated Proteins » Glycated Serum Proteins

Chemicals and Drugs [D] » Amino Acids, Peptides, and Proteins [D12] » Proteins » Blood Proteins » Glycated Serum Proteins

Chemicals and Drugs [D] » Amino Acids, Peptides, and Proteins [D12] » Proteins » Glycoproteins » Glycated Proteins » Glycated Serum Proteins

Chemicals and Drugs [D] » Biological Factors [D23] » Toxins, Biological » Glycation End Products, Advanced » Glycated Proteins » Glycated Serum Proteins

Description

Proteins in serum that have undergone, in vivo, non-enzymatic modification with reducing sugars via the MAILLARD REACTION. They are analyzed to measure control of HYPERGLYCEMIA.   MeSH

Hierarchy View

Subtype Terms (2)

Glycated Hemoglobin
2 drugs (1 approved, 1 experimental)

Hierarchy Tree View


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.